cognitive cybersecurity intelligence

News and Analysis

Search

FDA Issues Alert to Mitigate Risks to a Widely Used Allergy, Nausea Drug

The US Food and Drug Administration (FDA) has issued new guidelines recommending the intramuscular injection of generic drug promethazine hydrochloride, reducing the risk of severe chemical irritation and tissue damage. The medicine is used to manage allergic reactions, motion sickness and post-operative nausea and vomiting.

Source: medcitynews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

Connecting Tech to Black America

Tech evangelist David Lee spotlights the underrepresentation of Black Americans in tech, an issue he contends requires collective action to rectify. He suggests fostering connections

Zero-Day Attack Hits Cybersecurity Leader

The MITRE Corporation, a contributor to public interest cybersecurity, disclosed a data breach originating from a state-backed hack. Detected after suspicous activity was noticed on

Defining and Understanding Trust Assurance

Trust is essential for businesses and building it requires embracing the pillars of trust assurance: predictive, integrated, and transparent systems. Through trust assurance, businesses can